|
|
|
|
|
|
|
|
|
|
Director and CEO of Rambam Health Care Campus had a busy visit to the US: in New York City he met Chairman and CEO of General Electric, and in South Carolina he signed an agreement for joint stem cell research by RHCC, the Technion-Israel Institute of Technology, and MUSC.
By Dvora Kreda
"Innovations and Imagination in Medicine" were on display when Keynote Speaker Mr. Jeffrey R. Immelt, Chairman and CEO of General Electric, and Prof. Rafael Beyar, Director and CEO of Rambam Health Care Campus, met in New York City on November 14th to brainstorm before 150 invited guests of the American Friends of Rambam Medical Center (AFORAM).
 |
|
From right to left- Mr. Jeffrey R. Immelt, Mr. Eitan Wertheimer and Prof. Rafael Beyar in New York City
AFORAM |
The meeting of minds crackling with inventiveness came about naturally. Rambam is a key player in the success of Israel's high-tech "start-up" national economy, and fosters international R&D collaborations in such medically promising technologies as genetics, imaging, robotics, stents, and stem cells. GE established its presence in Israel in 1950, two year's after the State's establishment, making the venerable American company one of the first major U.S. corporations to operate in the new country.
 |
|
Representatives of the three institutions after signing the joint research agreement
MUSC |
In recent years, GE Healthcare Israel and Rambam's Institute of Nuclear Medicine have teamed up to develop PET/CT and SPECT/CT hybrid imaging scanners designed to examine a wide range of diseases – tumors, skeletal illnesses, infections, heart disease, and more. The breakthrough devices are currently in use or under assessment by oncologists, endocrinologists and cardiologists at Rambam and worldwide.
The event was hosted at J.P. Morgan global headquarters on Park Avenue. It opened with greetings by Mr. Adam Emmerich, Esq., President of AFORAM, and Mr. Michael Vaknin, Chief Economist for J.P. Morgan Asset Management & Private Banking. Mr. Eitan Wertheimer, Chairman of Israeli industrial giant Iscar Metal Cutting Co. (a Berkshire-Hathaway Company) and of Rambam Medical Center's Board of Trustees, delivered closing remarks.
Doing the Charleston
Then it was on to the Medical University of South Carolina for the host institution's first international "Frontiers in Cardiovascular Regeneration" symposium. Prof. Beyar and MUSC President Dr. Ray Greenberg signed an accord calling for joint pursuit of stem cell research by scientists at RHCC, the Technion-Israel Institute of Technology, and MUSC. The aim is to accelerate development of patentable and marketable stem cell techniques for the repair or replacement of damaged heart tissue, muscle, and arteries. The pact includes arrangements for bilateral visiting professorships and working sabbaticals, annual symposia, and joint grant applications to the National Institutes of Health (NIH).
With nearly 13,000 employees, MUSC is the largest non-federal employer in Charleston. Mayor Joe Riley proclaimed Nov. 17-18th MUSC-Technion-Rambam Collaboration Days in recognition of the potential brought to the city by the joint research effort.
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Main Link
: |
|
Link Title
: |
|
|
Url
: |
|
|
Choose existing Posting
|
|
Choose From Resource Gallery
|
|
|
|
|
|
|
|
|
|